Cytoplasmic utilization of human immunodeficiency virus type 1 genomic RNA is not dependent on a nuclear interaction with gag

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 2990-3002

  Grewe, Bastian ^a   Hoffmann, Bianca ^a   Ohs, Inga ^a   Blissenbach, Maik ^a   Brandt, Sabine ^b   Tippler, Bettina ^a   Grunwald, Thomas ^a   berla, Klaus U ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Medical Laboratory Bremen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GENOMIC RNA; PLASMID VECTOR; REV PROTEIN; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; REPORTER GENE; RNA SPLICING; RNA TRANSLATION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS INFECTIVITY;

CELL LINE; CELL NUCLEUS; CYTOPLASM; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; PROTEIN TRANSPORT; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS; ROUS SARCOMA VIRUS;

EID: 84857947884     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06874-11     Document Type: Article

References (69)

1. Abrahamyan LG, et al. 2010. Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA. J. Cell Sci. 123:369 -383.
2. Anson DS, Fuller M. 2003. Rational development of a HIV-1 gene therapy vector. J. Gene Med. 5:829-838.
3. Aricescu AR, Lu W, Jones EY. 2006. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D Biol. Crystallogr. 62:1243-1250.
4. Bériault V, et al. 2004. A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag, and Vpr localization. J. Biol. Chem. 279:44141- 44153.
5. Bieniasz PD. 2009. The cell biology of HIV-1 virion genesis. Cell Host Microbe 5:550 -558.
6. Blissenbach M, Grewe B, Hoffmann B, Brandt S, Uberla K. 2010. Nuclear RNA export and packaging functions of HIV-1 Rev revisited. J. Virol. 84:6598-6604.
7. Brandt S, et al. 2007. Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation. PLoS Pathog. 3:e54.
8. Brandt S, Grunwald T, Lucke S, Stang A, Uberla K. 2006. Functional replacement of the R region of simian immunodeficiency virus-based vectors by heterologous elements. J. Gen. Virol. 87:2297-2307.
9. Buck CB, et al. 2001. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J. Virol. 75:181-191.
10. Bukrinsky MI, et al. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365: 666-669.
11. Butsch M, Boris-Lawrie K. 2002. Destiny of unspliced retroviral RNA: ribosome and/or virion? J. Virol. 76:3089 -3094.
12. Butterfield-Gerson KL, Scheifele LZ, Ryan EP, Hopper AK, Parent LJ. 2006. Importin-beta family members mediate alpharetrovirus gag nuclear entry via interactions with matrix and nucleocapsid. J. Virol. 80:1798-1806.
13. Callahan EM, Wills JW. 2003. Link between genome packaging and rate of budding for Rous sarcoma virus. J. Virol. 77:9388 -9398.
14. Cochrane AW, McNally MT, Mouland AJ. 2006. The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology 3:18.
15. Cui Y, Iwakuma T, Chang LJ. 1999. Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function. J. Virol. 73:6171-6176.
16. Depienne C, et al. 2000. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp. Cell Res. 260:387-395.
17. D'Souza V, Summers MF. 2005. How retroviruses select their genomes. Nat. Rev. Microbiol. 3:643- 655.
18. Dupont S, et al. 1999. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 402:681- 685.
19. Felber BK, Zolotukhin AS, Pavlakis GN. 2007. Posttranscriptional control of HIV-1 and other retroviruses and its practical applications. Adv. Pharmacol. 55:161-197.
20. Fouchier RA, Meyer BE, Simon JH, Fischer U, Malim MH. 1997. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16:4531- 4539.
21. Gallay P, Swingler S, Song J, Bushman F, Trono D. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83:569 -576.
22. Gao F, et al. 2003. Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res. Hum. Retroviruses 19:817- 823.
23. Grewe B, Ü berla K. 2010. Rev revisited: additional functions of the HIV-1 Rev protein, p 439-470. In Lever AML, Jeang KT, Berkhout B (ed), Recent advances in human retroviruses: principles of replication and pathogenesis. World Scientific Publishing Co., Singapore.
24. Grigorov B, et al. 2007. Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers. Retrovirology 4:54.
25. Groom HC, Anderson EC, Lever AM. 2009. Rev: beyond nuclear export. J. Gen. Virol. 90:1303-1318.
26. Gudleski N, Flanagan JM, Ryan EP, Bewley MC, Parent LJ. 2010. Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA. Proc. Natl. Acad. Sci. U. S. A. 107:9358 -9363.
27. Gupta K, Ott D, Hope TJ, Siliciano RF, Boeke JD. 2000. A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions. J. Virol. 74:11811-11824.
28. Haffar OK, et al. 2000. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299:359 -368.
29. Hearps AC, Wagstaff KM, Piller SC, Jans DA. 2008. The N-terminal basic domain of the HIV-1 matrix protein does not contain a conventional nuclear localization sequence but is required forDNAbinding and protein self-association. Biochemistry 47:2199 -2210.
30. Jin J, Sturgeon T, Weisz OA, Mothes W, Montelaro RC. 2009. HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA trafficking. PLoS One 4:e6551.
31. Kemler I, Meehan A, Poeschla EM. 2010. Live-cell coimaging of the genomic RNAs and Gag proteins of two lentiviruses. J. Virol. 84:6352-6366.
32. Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA. 2000. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74:4839-4852.
33. Kudo N, et al. 1999. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. U. S. A. 96:9112-9117.
34. Kudo N, et al. 1998. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:540 -547.
35. Kutluay SB, Bieniasz PD. 2010. Analysis of the initiating events in HIV-1 particle assembly and genome packaging. PLoS Pathog. 6:e1001200.
36. Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF. 2006. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog. 2:e68.
37. LeBlanc JJ, Uddowla S, Abraham B, Clatterbuck S, Beemon KL. 2007. Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA. Virology 363:376 -386.
38. Lehmann M, et al. 2009. Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning. J. Biol. Chem. 284:14572-14585.
39. Lever AM. 2007. HIV-1 RNA packaging. Adv. Pharmacol. 55:1-32.
40. Lévesque K, et al. 2006. Trafficking of HIV-1 RNA is mediated by heterogeneous nuclear ribonucleoprotein A2 expression and impacts on viral assembly. Traffic 7:1177-1193.
41. Lu K, Heng X, Summers MF. 2011. Structural determinants and mechanism of HIV-1 genome packaging. J. Mol. Biol. 410:609-633.
42. Lucke S, Grunwald T, Uberla K. 2005. Reduced mobilization of Revresponsive element-deficient lentiviral vectors. J. Virol. 79:9359 -9362.
43. Malim MH, Hauber J, Fenrick R, Cullen BR. 1988. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335:181-183.
44. Mervis RJ, et al. 1988. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62:3993- 4002.
45. Moore MD, et al. 2007. Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J. Virol. 81:4002- 4011.
46. Moore MD, et al. 2009. Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses. PLoS Pathog. 5:e1000627.
47. Ogert RA, Lee LH, Beemon KL. 1996. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70: 3834-3843.
48. Ono A. 2009. HIV-1 assembly at the plasma membrane: Gag trafficking and localization. Future Virol. 4:241-257.
49. Paca RE, Ogert RA, Hibbert CS, Izaurralde E, Beemon KL. 2000. Rous sarcoma virus DR posttranscriptional elements use a novel RNA export pathway. J. Virol. 74:9507-9514.
50. Parent LJ. 2011. New insights into the nuclear localization of retroviral Gag proteins. Nucleus 2:92-97.
51. Parent LJ, Gudleski N. 2011. Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation. J. Mol. Biol. 410:553-564.
52. Perlman M, Resh MD. 2006. Identification of an intracellular trafficking and assembly pathway for HIV-1 gag. Traffic 7:731-745.
53. Poole E, Strappe P, Mok HP, Hicks R, Lever AM. 2005. HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic 6:741-755.
54. Poon DT, Chertova EN, Ott DE. 2002. Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging. Virology 293: 368-378.
55. Reil H, Bukovsky AA, Gelderblom HR, Gottlinger HG. 1998. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17:2699 -2708.
56. Rein A, Datta SA, Jones CP, Musier-Forsyth K. 2011. Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem. Sci. 36:373-380.
57. Renault N, et al. 2011. A nuclear export signal within the structural Gag protein is required for prototype foamy virus replication. Retrovirology 8:6.
58. Scheifele LZ, Garbitt RA, Rhoads JD, Parent LJ. 2002. Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc. Natl. Acad. Sci. U. S. A. 99:3944 -3949.
59. Scheifele LZ, Ryan EP, Parent LJ. 2005. Detailed mapping of the nuclear export signal in the Rous sarcoma virus Gag protein. J. Virol. 79:8732-8741.
60. Schnell T, Foley P, Wirth M, Munch J, Uberla K. 2000. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum. Gene Ther. 11:439-447.
61. Scholz I, et al. 2008. Analysis of human immunodeficiency virus matrix domain replacements. Virology 371:322-335.
62. Sharova N, Bukrinskaya A. 1991. p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells. AIDS Res. Hum. Retroviruses 7:303-306.
63. Srinivasakumar N, et al. 1997. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 71:5841-5848.
64. Terwilliger EF, Godin B, Sodroski JG, Haseltine WA. 1989. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc. Natl. Acad. Sci. U. S. A. 86:3857-3861.
65. Wagner R, et al. 2000. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum. Gene Ther. 11:2403-2413.
66. Wang CT, Zhang Y, McDermott J, Barklis E. 1993. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67:7067-7076.
67. Wolff B, Sanglier JJ, Wang Y. 1997. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Revdependent mRNA. Chem. Biol. 4:139 -147.
68. Yang J, Cullen BR. 1999. Structural and functional analysis of the avian leukemia virus constitutive transport element. RNA 5:1645-1655.
69. Zhang J, Crumpacker CS. 2002. Human immunodeficiency virus type 1 nucleocapsid protein nuclear localization mediates early viral mRNA expression. J. Virol. 76:10444 -10454.